Canadian-based venture capital firm Canopy Rivers Inc. (TSX: RIV)(OTC: CNPOF) reported that it generated operating income of $930 thousand in Canadian dollars versus last year’s $23 million for the same time period. The company also delivered a net loss of $4.4 million versus last year’s net income of $10.9 million. The stock dropped over 6% to lately trade at USD$1.
The company said that the income was “primarily driven by royalty, interest, and lease income of $2.2 million from: royalty and debenture agreements with Agripharm Corp., Greenhouse Juice Company, James E. Wagner Cultivation Corporation and Radicle Medical Marijuana Inc. a lease agreement with Spot Therapeutics Inc. and a shareholder loan agreement with PharmHouse, Inc. This income was partially offset by a $559 thousand net decrease in the fair value of certain financial assets that are reported at fair value through profit or loss.”
The company went on to say that the “Operating income was further offset by a $682 thousand share of loss from the Company’s equity method investees. This share of loss was recorded one quarter in arrears, which includes the Company’s common equity positions in Canapar Corp., Herbert Works, High Beauty, Inc., LeafLink Services International ULC, PharmHouse and Radicle.” Canopy Rivers said it also expects to continue to generate losses during the remainder of the year.
“Headlined by our graduation to the TSX, our business matured during the second quarter as we launched our Strategic Advisory Board and continued to work closely with our portfolio companies as they achieved new milestones,” said Narbé Alexandrian, President & CEO, Canopy Rivers. “There were numerous achievements for our portfolio companies this quarter. Several of these companies received licenses and amendments from Health Canada for the sale of cannabis oils, while others made key acquisitions, launched their Canadian business, or brokered agreements with companies both inside and outside of the Canopy Rivers ecosystem.”
The company noted that its operating expenses for the quarter were $6.1 million, which dropped from last year’s $8.9 million. $3.0 million of that was related to share-based compensation. Other operating expenses, which include consulting and professional fees and other general and administrative expenses, were $3.2 million, representing an increase from the comparative quarter last year due to the build-out of the Company’s management team and employee base and enhanced public company compliance, marketing and business development, and regulatory costs.
Other operating expenses also increased from the previous quarter due to certain non-recurring costs relating to the Company’s graduation to the Toronto Stock Exchange and the launch of a formal branding and marketing campaign.
Other comprehensive income, which captures the net changes in fair value of financial assets that are reported at fair value through other comprehensive income, was a loss of $28.3 million, net of tax. The fair values of Canopy Rivers’ investments in Eureka 93 Inc., JWC, YSS Corp., Les Serres Vert Cannabis Inc. and TerrAscend Corp. were negatively impacted by downward trends in public market valuations for cannabis companies during the period.
The company made no mention of its investment in the cannabis media outlet Civilized, which is said to be merging with New Frontier Data. Civilized recently laid off several staff members and moved to smaller offices in California. The rumor is that the planned combination will try to go public, which would attempt to make investors whole.